Stanley Paul Kutcher ONS (born 1951) is a Canadian Senator and Professor Emeritus of Psychiatry at Dalhousie University.
[4] Kutcher is a first generation Canadian born to Ukrainian refugees; his parents survived World War II and made a new life for themselves and their families in Canada.
[1] He credits his early life, particularly growing up in a household where community service to others was the norm, as full of the experiences that helped mould his values of civic engagement, that now inform his activities as a Senator.
[6] His postgraduate training in psychiatry was at the University of Toronto and he completed a McLaughlin Fellowship at the Medical Research Council Brain Metabolism Unit in Edinburgh.
[8] As a professor of psychiatry at Dalhousie University, he helped establish the Brain Repair Centre and the Life Sciences Development Association.
[9] He led the development and deployment of novel mental health competency training programs in Canada, the Caribbean and Latin America.
[11] Kutcher's academic portfolio includes over 400 published papers and numerous books on topics ranging from psychopharmacology to suicide prevention, adolescent brain development and Global School Mental Health.
[13] Study 329 became controversial when it was discovered that the article had been ghostwritten by a PR firm hired by SmithKline Beecham, had made inappropriate claims about the drug's efficacy, and had downplayed safety concerns.